Hi, Tim Plaehn here.
Gold just shattered another record, breaking through $5,000 per ounce for the first time ever.
In just the first 26 days of this year, gold has surged 15%...
Building on last year's historic 65% gain.
But I've found a smart way to play this gold surge.
It's a simple gold fund that's been quietly delivering up to 64% in yearly distributions — paid monthly — while gold climbs.
That means while others wait for gold to go higher…
You could already be collecting $1,152 a month.
Click here to discover this powerful gold income strategy and how it works.
The next payout could be just days away.
To your income,
Tim Plaehn
Lead Income Strategist
Momentum Is Just Starting for These 3 Rapid-Growth Stocks in 2026
Written by Nathan Reiff. Article Published: 2/2/2026.
In Brief
- Corvus Pharmaceuticals has nearly tripled in value this year amid optimism that its atopic dermatitis drug candidate will continue to deliver strong trial results.
- Despite legal and other hurdles, New Era Energy & Digital recently noted a key achievement in its path toward providing data center capacity.
- USA Rare Earth has received around $1.6 billion in federal funding as it seeks to provide a domestic alternative to foreign rare earth minerals.
Nearly one month into 2026, the S&P 500 has been fairly sluggish, rising just over 1% overall after several dips throughout January. That middling performance, however, masks the fact that a number of individual companies have had supercharged starts to the year, dramatically outperforming the market benchmark.
Investors looking to capitalize on firms with rising momentum in 2026 may consider Corvus Pharmaceuticals Inc. (NASDAQ: CRVS), New Era Energy & Digital Inc. (NASDAQ: NUAI), and USA Rare Earth (NASDAQ: USAR), each of which has returned at least 56% year-to-date (YTD).
Analysts Stay Bullish on Corvus With 50%+ Upside Targets
Silicon Valley Insiders are getting spooked about AI - here's why (Ad)
Almost no one sees it coming, but AI is about to split America into two over the next 12 months. On one hand, it'll make America's one-percenters richer and more powerful than ever. On the other hand, it's set to trap millions of hardworking Americans in financial quicksand. Former Google exec Kai-Fu Lee says AI could wipe out 50% of jobs by 2027. Elon Musk has said AI will surpass human intelligence by 2027. Mark Zuckerberg has said half of all coding could be done by AI within the next year. One ex-hedge fund manager whose team predicted Nvidia's rise in 2020 calls this the AI End Game, and he says there are three critical moves every American should make in the next 12 months to protect and grow their wealth through this paradigm shift.
See the three moves before the AI split happensAs a clinical-stage biopharma company, Corvus operates in a sector prone to rapid, sizable stock swings. A recent catalyst for Corvus's share-price move was positive data from its Phase 1 trial of soquelitinib, a drug candidate for atopic dermatitis and other conditions. In mid-January, Corvus reported promising Phase 1 results, including a 72% reduction in eczema severity for patients in the trial.
That news helped Corvus shares surge roughly 188% YTD. A Phase 2 trial is planned for early this year and could push the shares higher. To fund the upcoming study, Corvus launched a $150 million equity offering to extend its cash runway, although that move risks diluting current shareholders. The financing is important because Corvus finished the third quarter of 2025 with only $67 million in cash on hand.
While the company is clearly betting on soquelitinib, the addressable market for atopic dermatitis is large. Analysts remain optimistic: six of seven rate CRVS a Buy, and the consensus price target implies roughly 51% additional upside even after the recent rally.
New Era's Data Center Pivot Makes Big Strides, Though Legal and Other Risks Remain
New Era & Digital is one of the more polarizing names in the energy exploration and production space this year. Shares of NUAI are up more than 114% YTD after the company announced a January partnership with Primary Digital Infrastructure to co-develop up to 1 gigawatt of hyperscale data center capacity in Texas. Earlier in the month New Era also closed the acquisition of a 50% interest in Texas Critical Data Centers, further positioning the company for a pivot into the high-demand data center market.
Those moves suggest New Era could make meaningful progress on its reorganization plans. At the same time, the company faces legal scrutiny: the Rosen Law Firm announced plans to investigate allegations of "materially misleading business information." New Era is also relatively small, with a market value just under $400 million, which adds to its risk profile. Still, investors willing to accept those risks may be rewarded if the rally continues.
USA Rare Earth Looks to Fill a Significant Supply Chain Need With Government Support
Rare-earth minerals are increasingly vital for a wide range of technologies, and supply-chain and geopolitical concerns threaten U.S. supplies. USA Rare Earth aims to ease those worries by providing a domestic alternative. The company has been buoyed by a $1.6-billion investment from the federal government and additional private investments in recent weeks, and it reported a strong cash position alongside its latest earnings.
The firm's rare-earth and magnet production capacity is expanding rapidly, driven by key operations in Texas, and revenues are expected to grow substantially. That said, USA Rare Earth remains an early-stage company without a proven history of consistent profitability, which may deter some investors. Still, its 56% YTD return and a strongly optimistic analyst profile suggest it could be positioned for significant growth if execution proceeds as planned.
This email message is a paid advertisement from Investors Alley, a third-party advertiser of The Early Bird and MarketBeat.
Information contained in this email and websites maintained by Magnifi Communities LLC (dba Investors Alley) are for educational purposes only and are neither an offer nor a recommendation to buy or sell any security.
Past performance is not necessarily indicative of future results. Trading and investing involve risk, and you may lose your principal investment.
All information contained herein is copyright 2025, Magnifi Communities LLC.
If you need help with your newsletter, feel free to contact our U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, S.D. 57103-7078. United States..
No comments:
Post a Comment